Ferraro, F.; Steinle, A.; Narasimhan, H.; Bleilevens, A.; Stolzenberg, P.-M.; Braunschweig, T.; Stickeler, E.; Maurer, J.
IRAK2 Downregulation in Triple-Negative Breast Cancer Cells Decreases Cellular Growth In Vitro and Delays Tumour Progression in Murine Models. Int. J. Mol. Sci. 2023, 24, 2520.
https://doi.org/10.3390/ijms24032520
AMA Style
Ferraro F, Steinle A, Narasimhan H, Bleilevens A, Stolzenberg P-M, Braunschweig T, Stickeler E, Maurer J.
IRAK2 Downregulation in Triple-Negative Breast Cancer Cells Decreases Cellular Growth In Vitro and Delays Tumour Progression in Murine Models. International Journal of Molecular Sciences. 2023; 24(3):2520.
https://doi.org/10.3390/ijms24032520
Chicago/Turabian Style
Ferraro, Francesca, Anja Steinle, Harini Narasimhan, Andreas Bleilevens, Paula-Marie Stolzenberg, Till Braunschweig, Elmar Stickeler, and Jochen Maurer.
2023. "IRAK2 Downregulation in Triple-Negative Breast Cancer Cells Decreases Cellular Growth In Vitro and Delays Tumour Progression in Murine Models" International Journal of Molecular Sciences 24, no. 3: 2520.
https://doi.org/10.3390/ijms24032520
APA Style
Ferraro, F., Steinle, A., Narasimhan, H., Bleilevens, A., Stolzenberg, P. -M., Braunschweig, T., Stickeler, E., & Maurer, J.
(2023). IRAK2 Downregulation in Triple-Negative Breast Cancer Cells Decreases Cellular Growth In Vitro and Delays Tumour Progression in Murine Models. International Journal of Molecular Sciences, 24(3), 2520.
https://doi.org/10.3390/ijms24032520
